Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Papaveretum
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Papaveretum 15.4mg/1ml solution for injection ampoules
0407020ABAAABAB
|
Papaveretum | Papaveretum | Central Nervous System | No data available |
|
Papaveretum 15.4mg/Hyoscine hydrobrom 400microg/1ml inj amp
0407020ABAAAIAI
|
Papaveretum | Papaveretum | Central Nervous System | No data available |
|
Papaveretum 30mg/1ml solution for injection ampoules
0407020ABAAAPAP
|
Papaveretum | Papaveretum | Central Nervous System | No data available |
|
Papaveretum 40mg/1ml solution for injection ampoules
0407020ABAAAKAK
|
Papaveretum | Papaveretum | Central Nervous System | No data available |
|
Papaveretum 7.7mg/1ml solution for injection ampoules
0407020ABAAAAAA
|
Papaveretum | Papaveretum | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.